
© 2024 Der Aktionär
Realtime | Geld | Brief | Zeit |
---|---|---|---|
82,10 | 83,22 | 04.04. | |
81,72 | 84,28 | 04.04. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Di | Lantheus bolsters radiopharmaceutical portfolio with acquisition | ||
Di | Lantheus Holdings, Inc. - 8-K, Current Report | ||
Di | Lantheus stärkt Radiopharmaka-Portfolio durch Übernahme | ||
Di | Lantheus Holdings, Inc.: Lantheus Completes Acquisition of Evergreen Theragnostics | BEDFORD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians... ► Artikel lesen | |
07.03. | Lantheus Holdings-Präsident Paul Blanchfield verkauft Aktien im Wert von 204.232 US-Dollar |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Do | TELIX PHARMACEUTICALS LIMITED: Application for quotation of securities - TLX | ||
Do | TELIX PHARMACEUTICALS LIMITED: Notification of cessation of securities - TLX | ||
Do | TELIX PHARMACEUTICALS LIMITED: Pending Release of Shares from Voluntary Escrow | ||
Mi | TELIX PHARMACEUTICALS LIMITED: App 3X Initial Director Interests - A Whitaker | ||
Mi | TELIX PHARMACEUTICALS LIMITED: Anne Whitaker Appointed as Non-Executive Director |
Unternehmen / Aktien | Kurs | % |
---|---|---|
LANTHEUS HOLDINGS INC | 82,70 | -0,36 % |
TELIX PHARMACEUTICALS LIMITED | 12,400 | +1,64 % |